SCHEMBL13600090

SCHEMBL13600090

O=C(O)c1ccc(C(=O)c2ccccn2)cc1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.81
NAPRT Q6XQN6 2/20 0.64
LMNA P02545 1/20 0.64
P4HTM Q9NXG6 1/20 0.64
L3MBTL1 Q9Y468 1/20 0.64
SRD5A2 P31213 3/20 0.57
HSD17B14 Q9BPX1 1/20 0.57
CES2 O00748 1/20 0.55
CES1 P23141 1/20 0.55
ALDH1A1 P00352 1/20 0.52
POLB P06746 1/20 0.49
KDM4E B2RXH2 2/20 0.49
DAO P14920 1/20 0.48
TSHR P16473 1/20 0.48
MAPT P10636 1/20 0.48
TLR7 Q9NYK1 1/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
KDM6B O15054 1/20 0.47
KDM4A O75164 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL398165 0.90 KMT2A (1.00) KMT2ANAPRTLMNAP4HTML3MBTL1
SCHEMBL29373829 0.90 KMT2A (1.00) KMT2ANAPRTLMNAP4HTML3MBTL1
SCHEMBL28005707 0.88 KMT2A (0.96) KMT2ANAPRTLMNAP4HTML3MBTL1
SCHEMBL28015961 0.88 KMT2A (0.96) KMT2ANAPRTLMNAP4HTML3MBTL1
SCHEMBL29571462 0.85 KMT2A (0.75) KMT2ANAPRTLMNAP4HTML3MBTL1
SCHEMBL2485773 0.85 KMT2A (0.75) KMT2ANAPRTLMNAP4HTML3MBTL1
SCHEMBL507907 0.83 KMT2A (0.72) KMT2ANAPRTLMNAP4HTML3MBTL1
SCHEMBL743166 0.83 KMT2A (0.72) KMT2ANAPRTLMNAP4HTML3MBTL1
SCHEMBL8866141 0.83 KMT2A (0.72) KMT2ANAPRTLMNAP4HTML3MBTL1
SCHEMBL1156133 0.83 KMT2A (0.72) KMT2ANAPRTLMNAP4HTML3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7638531-B2 Phenoxypiperidines and analogs thereof useful as histamine H3 antagonists SCHERING CORPORATION (US) 2009-12-29 US disclosed
US-7638531-B2 Phenoxypiperidines and analogs thereof useful as histamine H3 antagonists SCHERING CORPORATION (US) 2009-12-29 US disclosed
US-20070167435-A1 Phenoxypiperidines and analogs thereof useful as histamine H3 antagonists SCHERING CORPORATION 2007-07-19 US disclosed
US-20070167435-A1 Phenoxypiperidines and analogs thereof useful as histamine H3 antagonists SCHERING CORPORATION 2007-07-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070167435-A1 Phenoxypiperidines and analogs thereof useful as histamine H3 antagonists HRH4, HRH3, HRH2 KMT2A 1324/4885NAPRT 3026/4885LMNA 4131/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.